Archive for the ‘OncoVex’ Category

Amgen Acquiring BioVex For $1 Billion

Amit Chowdhry | January 26, 2011 | 532 views | Add a Comment
Categorized under , ,


Amgen, a human therapeutics company that focuses on advances in recombinant DNA will be acquiring BioVex Group for $1 billion. BioVex is a biotechnology company that works on the treatment of cancer.

Copyright 2011 Pulse 2, LLC | About | Privacy Statement